LaBarre Michael J. has filed 117 insider transactions across 1 company since January 2024.
Most recent transaction: a sale of 9300 shares of HALOZYME THERAPEUTICS, INC. ($HALO) on February 25, 2025.
Activity breakdown: 0 open-market purchases and 30 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 25, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 9300 | $58.01 | 186,153.0000 | 129,424,000 | 4.76% | 0.01% |
| Feb. 25, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 700 | $58.67 | 185,453.0000 | 129,424,000 | 0.38% | 0.00% |
| Feb. 26, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 9400 | $58.09 | 176,053.0000 | 129,424,000 | 5.07% | 0.01% |
| Feb. 26, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 600 | $58.65 | 175,453.0000 | 129,424,000 | 0.34% | 0.00% |
| Feb. 27, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 1597 | $58.25 | 173,856.0000 | 129,424,000 | 0.91% | 0.00% |
| Feb. 27, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 100 | $58.74 | 173,756.0000 | 129,424,000 | 0.06% | 0.00% |
| Feb. 23, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 4747 | $0.00 | 197,863.0000 | 129,424,000 | 2.46% | 0.00% |
| Feb. 23, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | F | Common Stock | 2410 | $57.75 | 195,453.0000 | 129,424,000 | 1.22% | 0.00% |
| Feb. 23, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Restricted Stock Units | 4747 | $0.00 | 14,238.0000 | 129,424,000 | 25.00% | 0.00% |
| Feb. 20, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | A | Option to Purchase Common Stock | 11902 | $0.00 | 11,902.0000 | 129,424,000 | 9999.99% | 0.01% |
| Feb. 20, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | A | Restricted Stock Units | 11230 | $0.00 | 11,230.0000 | 129,424,000 | 9999.99% | 0.01% |
| Feb. 15, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 3386 | $0.00 | 177,142.0000 | 129,424,000 | 1.95% | 0.00% |
| Feb. 15, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | F | Common Stock | 1304 | $58.29 | 175,838.0000 | 129,424,000 | 0.74% | 0.00% |
| Feb. 16, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 20891 | $0.00 | 196,729.0000 | 129,424,000 | 11.88% | 0.02% |
| Feb. 16, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | F | Common Stock | 8721 | $58.29 | 188,008.0000 | 129,424,000 | 4.43% | 0.01% |
| Feb. 16, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 6112 | $0.00 | 194,120.0000 | 129,424,000 | 3.25% | 0.00% |
| Feb. 16, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | F | Common Stock | 3103 | $58.29 | 191,017.0000 | 129,424,000 | 1.60% | 0.00% |
| Feb. 16, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 4263 | $0.00 | 195,280.0000 | 129,424,000 | 2.23% | 0.00% |
| Feb. 16, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | F | Common Stock | 2164 | $58.29 | 193,116.0000 | 129,424,000 | 1.11% | 0.00% |
| Feb. 15, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Restricted Stock Units | 3386 | $0.00 | 0.0000 | 129,424,000 | 100.00% | 0.00% |
| Feb. 16, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Performance Stock Units | 20891 | $0.00 | 0.0000 | 129,424,000 | 100.00% | 0.02% |
| Feb. 16, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Restricted Stock Units | 6112 | $0.00 | 6,112.0000 | 129,424,000 | 50.00% | 0.00% |
| Feb. 16, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Restricted Stock Units | 4263 | $0.00 | 8,526.0000 | 129,424,000 | 33.33% | 0.00% |
| Feb. 12, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | A | Performance Stock Units | 7262 | $0.00 | 20,891.0000 | 129,424,000 | 53.28% | 0.01% |
| Feb. 12, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | A | Performance Stock Units | 4177 | $0.00 | 6,547.0000 | 129,424,000 | 176.24% | 0.00% |
| Feb. 12, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | A | Performance Stock Unit | 4921 | $0.00 | 4,921.0000 | 129,424,000 | 9999.99% | 0.00% |
| Feb. 12, 2025 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | A | Performance Stock Units | 20342 | $0.00 | 20,342.0000 | 129,424,000 | 9999.99% | 0.02% |
| Oct. 15, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 5509 | $16.65 | 179,265.0000 | 130,134,000 | 3.17% | 0.00% |
| Oct. 15, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 4491 | $19.98 | 183,756.0000 | 130,134,000 | 2.51% | 0.00% |
| Oct. 15, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 9923 | $53.74 | 173,833.0000 | 130,134,000 | 5.40% | 0.01% |
| Oct. 15, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 77 | $54.25 | 173,756.0000 | 130,134,000 | 0.04% | 0.00% |
| Oct. 16, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 10000 | $19.98 | 183,756.0000 | 130,134,000 | 5.76% | 0.01% |
| Oct. 16, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 10000 | $53.26 | 173,756.0000 | 130,134,000 | 5.44% | 0.01% |
| Oct. 15, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 5509 | $0.00 | 6,352.0000 | 130,134,000 | 46.45% | 0.00% |
| Oct. 15, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 4491 | $0.00 | 36,608.0000 | 130,134,000 | 10.93% | 0.00% |
| Oct. 16, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 10000 | $0.00 | 26,608.0000 | 130,134,000 | 27.32% | 0.01% |
| Sept. 17, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 10000 | $16.65 | 183,756.0000 | 134,197,000 | 5.76% | 0.01% |
| Sept. 17, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 10000 | $62.88 | 173,756.0000 | 134,197,000 | 5.44% | 0.01% |
| Sept. 18, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 10000 | $16.65 | 183,756.0000 | 134,197,000 | 5.76% | 0.01% |
| Sept. 18, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 7963 | $61.89 | 175,793.0000 | 134,197,000 | 4.33% | 0.01% |
| Sept. 18, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 2037 | $62.58 | 173,756.0000 | 134,197,000 | 1.16% | 0.00% |
| Sept. 17, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 10000 | $0.00 | 21,861.0000 | 134,197,000 | 31.39% | 0.01% |
| Sept. 18, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 10000 | $0.00 | 11,861.0000 | 134,197,000 | 45.74% | 0.01% |
| Aug. 27, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 5580 | $18.41 | 173,756.0000 | 134,197,000 | 3.32% | 0.00% |
| Aug. 27, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 5580 | $0.00 | 0.0000 | 134,197,000 | 100.00% | 0.00% |
| Aug. 20, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 10000 | $16.65 | 178,176.0000 | 134,197,000 | 5.95% | 0.01% |
| Aug. 20, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 10000 | $61.06 | 168,176.0000 | 134,197,000 | 5.61% | 0.01% |
| Aug. 21, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 10000 | $16.65 | 178,176.0000 | 134,197,000 | 5.95% | 0.01% |
| Aug. 21, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 9900 | $61.74 | 168,276.0000 | 134,197,000 | 5.56% | 0.01% |
| Aug. 21, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 100 | $62.34 | 168,176.0000 | 134,197,000 | 0.06% | 0.00% |
| Aug. 20, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 10000 | $0.00 | 41,861.0000 | 134,197,000 | 19.28% | 0.01% |
| Aug. 21, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 10000 | $0.00 | 31,861.0000 | 134,197,000 | 23.89% | 0.01% |
| July 23, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 10000 | $8.11 | 178,176.0000 | 134,197,000 | 5.95% | 0.01% |
| July 23, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 4709 | $54.46 | 173,467.0000 | 134,197,000 | 2.64% | 0.00% |
| July 23, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 5291 | $55.27 | 168,176.0000 | 134,197,000 | 3.05% | 0.00% |
| July 24, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 1715 | $8.11 | 169,891.0000 | 134,197,000 | 1.02% | 0.00% |
| July 24, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 8285 | $16.65 | 178,176.0000 | 134,197,000 | 4.88% | 0.01% |
| July 24, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 10000 | $55.12 | 168,176.0000 | 134,197,000 | 5.61% | 0.01% |
| July 23, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 10000 | $0.00 | 1,715.0000 | 134,197,000 | 85.36% | 0.01% |
| July 24, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 1715 | $0.00 | 0.0000 | 134,197,000 | 100.00% | 0.00% |
| July 24, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 8285 | $0.00 | 51,861.0000 | 134,197,000 | 13.77% | 0.01% |
| June 18, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 10000 | $8.11 | 178,176.0000 | 134,197,000 | 5.95% | 0.01% |
| June 18, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 10000 | $49.43 | 168,176.0000 | 134,197,000 | 5.61% | 0.01% |
| June 18, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 10000 | $0.00 | 11,715.0000 | 134,197,000 | 46.05% | 0.01% |
| May 21, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 10000 | $8.11 | 178,176.0000 | 134,197,000 | 5.95% | 0.01% |
| May 21, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 10000 | $45.16 | 168,176.0000 | 134,197,000 | 5.61% | 0.01% |
| May 22, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 10000 | $8.11 | 178,176.0000 | 134,197,000 | 5.95% | 0.01% |
| May 22, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 10000 | $45.38 | 168,176.0000 | 134,197,000 | 5.61% | 0.01% |
| May 21, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 10000 | $0.00 | 31,715.0000 | 134,197,000 | 23.97% | 0.01% |
| May 22, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 10000 | $0.00 | 21,715.0000 | 134,197,000 | 31.53% | 0.01% |
| April 16, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 10000 | $8.11 | 178,176.0000 | 134,197,000 | 5.95% | 0.01% |
| April 16, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 10000 | $38.35 | 168,176.0000 | 134,197,000 | 5.61% | 0.01% |
| April 17, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 10000 | $8.11 | 178,176.0000 | 134,197,000 | 5.95% | 0.01% |
| April 17, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 10000 | $38.49 | 168,176.0000 | 134,197,000 | 5.61% | 0.01% |
| April 16, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 10000 | $0.00 | 51,715.0000 | 134,197,000 | 16.20% | 0.01% |
| April 17, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 10000 | $0.00 | 41,715.0000 | 134,197,000 | 19.34% | 0.01% |
| March 26, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 8436 | $12.07 | 164,994.0000 | 134,197,000 | 5.39% | 0.01% |
| March 26, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 292 | $16.78 | 165,286.0000 | 134,197,000 | 0.18% | 0.00% |
| March 26, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 2890 | $8.11 | 168,176.0000 | 134,197,000 | 1.75% | 0.00% |
| March 26, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 8436 | $0.00 | 0.0000 | 134,197,000 | 100.00% | 0.01% |
| March 26, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 292 | $0.00 | 0.0000 | 134,197,000 | 100.00% | 0.00% |
| March 26, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 2890 | $0.00 | 61,715.0000 | 134,197,000 | 4.47% | 0.00% |
| March 12, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 10000 | $12.07 | 166,558.0000 | 134,197,000 | 6.39% | 0.01% |
| March 12, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 10000 | $41.64 | 156,558.0000 | 134,197,000 | 6.00% | 0.01% |
| March 13, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 6449 | $12.07 | 163,007.0000 | 134,197,000 | 4.12% | 0.00% |
| March 13, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 3551 | $8.11 | 166,558.0000 | 134,197,000 | 2.18% | 0.00% |
| March 13, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 10000 | $42.27 | 156,558.0000 | 134,197,000 | 6.00% | 0.01% |
| March 12, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 10000 | $0.00 | 14,885.0000 | 134,197,000 | 40.18% | 0.01% |
| March 13, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 6449 | $0.00 | 8,436.0000 | 134,197,000 | 43.33% | 0.00% |
| March 13, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 3551 | $0.00 | 64,605.0000 | 134,197,000 | 5.21% | 0.00% |
| Feb. 27, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 10000 | $39.95 | 159,087.0000 | 134,197,000 | 5.91% | 0.01% |
| Feb. 28, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 2529 | $39.56 | 156,558.0000 | 134,197,000 | 1.59% | 0.00% |
| Feb. 28, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 7471 | $8.11 | 164,029.0000 | 134,197,000 | 4.77% | 0.01% |
| Feb. 28, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 7471 | $39.54 | 156,558.0000 | 134,197,000 | 4.55% | 0.01% |
| Feb. 28, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 7471 | $0.00 | 68,156.0000 | 134,197,000 | 9.88% | 0.01% |
| Feb. 23, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | A | Option to Purchase Common Stock | 19674 | $0.00 | 19,674.0000 | 134,197,000 | 9999.99% | 0.01% |
| Feb. 23, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | A | Restricted Stock Units | 18985 | $0.00 | 18,985.0000 | 134,197,000 | 9999.99% | 0.01% |
| Feb. 16, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 6112 | $0.00 | 170,080.0000 | 134,197,000 | 3.73% | 0.00% |
| Feb. 16, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | F | Common Stock | 3097 | $36.10 | 166,983.0000 | 134,197,000 | 1.82% | 0.00% |
| Feb. 16, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 4264 | $0.00 | 171,247.0000 | 134,197,000 | 2.55% | 0.00% |
| Feb. 16, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | F | Common Stock | 2160 | $36.10 | 169,087.0000 | 134,197,000 | 1.26% | 0.00% |
| Feb. 16, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Restricted Stock Units | 6112 | $0.00 | 12,224.0000 | 134,197,000 | 33.33% | 0.00% |
| Feb. 16, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Restricted Stock Units | 4264 | $0.00 | 12,789.0000 | 134,197,000 | 25.00% | 0.00% |
| Feb. 15, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 3386 | $0.00 | 160,529.0000 | 134,197,000 | 2.15% | 0.00% |
| Feb. 15, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | F | Common Stock | 1208 | $35.91 | 159,321.0000 | 134,197,000 | 0.75% | 0.00% |
| Feb. 15, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | A | Common Stock | 8479 | $0.00 | 167,800.0000 | 134,197,000 | 5.32% | 0.01% |
| Feb. 15, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | F | Common Stock | 3832 | $35.91 | 163,968.0000 | 134,197,000 | 2.28% | 0.00% |
| Feb. 15, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Restricted Stock Units | 3386 | $0.00 | 3,386.0000 | 134,197,000 | 50.00% | 0.00% |
| Feb. 10, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 8133 | $0.00 | 160,044.0000 | 134,197,000 | 5.35% | 0.01% |
| Feb. 10, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | F | Common Stock | 2901 | $35.49 | 157,143.0000 | 134,197,000 | 1.81% | 0.00% |
| Feb. 10, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Restricted Stock Units | 8133 | $0.00 | 0.0000 | 134,197,000 | 100.00% | 0.01% |
| Jan. 16, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 10000 | $12.07 | 161,911.0000 | 134,197,000 | 6.58% | 0.01% |
| Jan. 16, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 10000 | $36.00 | 151,911.0000 | 134,197,000 | 6.18% | 0.01% |
| Jan. 17, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Common Stock | 10000 | $12.07 | 161,911.0000 | 134,197,000 | 6.58% | 0.01% |
| Jan. 17, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | S | Common Stock | 10000 | $36.00 | 151,911.0000 | 134,197,000 | 6.18% | 0.01% |
| Jan. 16, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 10000 | $0.00 | 34,885.0000 | 134,197,000 | 22.28% | 0.01% |
| Jan. 17, 2024 | HALOZYME THERAPEUTICS, INC. | $HALO | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | M | Option to Purchase Common Stock | 10000 | $0.00 | 24,885.0000 | 134,197,000 | 28.67% | 0.01% |